15-48487362-C-T
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The ENST00000316623.10(FBN1):c.3413G>A(p.Cys1138Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C1138F) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000316623.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.3413G>A | p.Cys1138Tyr | missense_variant | 28/66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.3413G>A | p.Cys1138Tyr | missense_variant | 27/65 | NP_001393645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.3413G>A | p.Cys1138Tyr | missense_variant | 28/66 | 1 | NM_000138.5 | ENSP00000325527 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Marfan syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 07, 2018 | The p.Cys1138Tyr variant in FBN1 has been reported in an individual with clinica l features of Marfan syndrome (Comeglio 2007) and was absent from large populati on studies. Computational prediction tools and conservation analysis suggest tha t the p.Cys1138Tyr variant may impact the protein. Additional missense variants at this amino acid position (p.Cys1138Phe, p.Cys1138Arg, p.Cys1138Gly, and p.Cys 1138Ser) have been reported in association with Marfan syndrome or other FBN1-re lated disorders (Stheneur 2009, Lerner-Ellis 2014, UMD-FBN1 database; Collod-Ber oud 2003), suggesting that changes at this position in not tolerated. Additiona lly, the p.Cys1138Tyr variant affects a cysteine residue within a calcium-bindin g EGF-like domain of the FBN1 gene, which may affect disulfide bonding and is pr edicted to alter the structure and function of the protein. Cysteine substitutio ns in the calcium-binding EGF-like domains represent the majority of pathogenic missense changes associated with Marfan syndrome (Vollbrandt 2004). In summary, although additional studies are required to fully establish its clinical signifi cance, the p.Cys1138Tyr variant is likely pathogenic. ACMG/AMP Criteria applied (Richards 2015): PS4-Supporting, PM1, PM2, PP3. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at